OCPNF (Olympus) Short-term investments

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OCPNF Olympus Corp OCPNF
84 GF Score
Price $13.20
GF Value $16.36
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Olympus Short-term investments?

Short-term investments only applies to insurance companies.

OCPNF
84GF Score
Olympus Corp OCPNF
Short-term investments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Olympus (OCPNF) Overvalued in 2026?

Based on GuruFocus' analysis, Olympus stock appears to be undervalued. The current stock price of $13.20 is trading 19.3% below its estimated GF Value™ of $16.36. GuruFocus considers Olympus to be Modestly Undervalued.

Key valuation signals for OCPNF:

  • Short-term investments:
  • GF Value™: $16.36 vs. price of $13.20 (19.3% below fair value)
  • GF Score™: 84/100 with 6 warning signs

No single metric tells the full story. See the OCPNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Olympus Business Description

Address 2951 Ishikawacho, Hachioji, JPN, 192-8507
Olympus is a medical-device maker with a leading position in the endoscope market and a diversified global revenue stream. Originally founded in 1919 in Japan as a microscope and camera maker, Olympus has gradually pivoted into endoscopic and therapeutic solutions. As of March 2025, more than 60% of its revenue comes from endoscopic solutions. In addition, North America is the biggest revenue contributor by region, accounting for 38% of its total revenue.
84GF Score

Get the complete analysis for OCPNF

Short-term investments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.20
Price
$16.36
GF Value